The use of biologics and small molecules in pregnant patients with rheumatic diseases

Expert Review of Clinical Pharmacology
Maria GerosaCecilia Beatrice Chighizola

Abstract

Biological agents have radically changed the prognosis of rheumatic patients. Current evidence demonstrates that tight disease control during pregnancy is mandatory to minimize adverse outcome risk. As the new therapeutic tools are pivotal to maintain appropriate disease activity, it is timely to review available evidence about the safety of biologics and small molecules in pregnancy. Areas covered: A comprehensive literature review has been performed, reporting available data about the passage into breast milk, rate of pregnancy loss and fetal malformations, and long-term complications due to in utero exposure to biological agents and small molecules. Expert commentary: Data about the safety of agents against tumor necrosis factor in pregnancy are reassuring. Even rituximab, tocilizumab, belimumab, ustekinumab, secukinumab, and abatacept have not been associated with an increased rate of fetal abnormalities or adverse pregnancy outcome. Experience with small molecules is too small to draw any conclusion. Even if further data are warranted to define the possible long-term effects of in utero biologic exposure on the infant immune system development, it is reasonable to speculate that in the next future the use of biologics duri...Continue Reading

References

Jun 1, 1989·Genitourinary Medicine·M Rademaker, A Forsyth
May 10, 1995·The New Zealand Medical Journal·M RademakerM B Duffill
Jun 20, 2003·The New England Journal of Medicine·Philip N HawkinsMichael F McDermott
Aug 21, 2003·Zeitschrift für Rheumatologie·Andrea Rubbert-Roth, Andreas Perniok
Oct 11, 2003·Transplant Immunology·Carsten SchröderRichard N Pierson
Aug 12, 2005·Current Opinion in Rheumatology·Silvia Stojanov, Daniel L Kastner
Jun 6, 2009·The New England Journal of Medicine·Helen J LachmannUNKNOWN Canakinumab in CAPS Study Group
Jul 1, 2009·Arthritis and Rheumatism·Pierre YouinouYves Renaudineau
Sep 17, 2009·The American Journal of Gastroenterology·Gil Y MelmedEric A Vasiliauskas
Jan 16, 2010·Annals of the New York Academy of Sciences·Raphaela Goldbach-Mansky
Jun 12, 2010·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Pauline L MartinGeorge Treacy
Jul 17, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Thao PhamUNKNOWN Club Rhumatismes et Inflammation (CRI)
Oct 13, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Anu VaidyanathanJoseph C Beyer
Nov 26, 2010·Blood·Eliza F ChakravartyPamela Farmer
Apr 6, 2011·Dermatology : International Journal for Clinical and Investigative Dermatology·Nicolas KlugerDidier Bessis
Nov 15, 2011·Journal of Autoimmunity·Olga L QuinteroJuan-Manuel Anaya
Aug 10, 2012·The New England Journal of Medicine·Ronald F van VollenhovenUNKNOWN ORAL Standard Investigators
Oct 30, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Zuzana ZelinkovaUNKNOWN Dutch Delta IBD Group
Dec 4, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Uma MahadevanMaria T Abreu
Jun 19, 2014·The New England Journal of Medicine·Eun Bong LeeUNKNOWN ORAL Start Investigators
Sep 6, 2014·Expert Opinion on Drug Safety·Maria GerosaRolando Cimaz
Sep 17, 2014·Arthritis & Rheumatology·Zenas ChangPamela Stratton
Oct 1, 2014·Pediatrics·Tamazoust GuiddirLoïc de Pontual
Dec 6, 2014·Rheumatology·May Ching Soh, Catherine Nelson-Piercy
Dec 30, 2014·Expert Review of Clinical Immunology·Natasha Jordan, David P D'Cruz
Jan 4, 2015·Autoimmunity Reviews·Monika ØstensenMichael von Wolff
Jan 6, 2015·International Journal of Rheumatic Diseases·Shingo NakayamadaYoshiya Tanaka
Apr 4, 2015·The Journal of Rheumatology·Vaneet K SandhuMichael H Weisman
Apr 16, 2015·Expert Review of Clinical Immunology·Melissa B HoffmanSteven R Feldman
May 7, 2015·Alimentary Pharmacology & Therapeutics·K R Forgan-Smith, J E Roche
Jul 27, 2015·Seminars in Arthritis and Rheumatism·Monica KumarTeresa A Simon
Sep 17, 2015·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Gabriella BrömsHelle Kieler
Jan 5, 2016·Digestive Diseases and Sciences·Sarah SheibaniUma Mahadevan

❮ Previous
Next ❯

Citations

Jun 7, 2019·Current Opinion in Rheumatology·Luis J JaraMiguel A Saavedra
Aug 30, 2019·Current Opinion in Rheumatology·Wendy Marder
Feb 20, 2020·Therapeutic Advances in Musculoskeletal Disease·Giulia CostanzoStefano Del Giacco
Mar 13, 2020·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·Maximilian Riedel, Bettina Kuschel
Apr 3, 2020·Zeitschrift für Rheumatologie·R Fischer-Betz, I Haase
Jan 26, 2021·Journal of Developmental Origins of Health and Disease·Michael D WieseJanna L Morrison
Feb 7, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·A NastC Dressler
Feb 19, 2021·Expert Opinion on Drug Safety·Anna Viola TaulaigoLaura Andreoli
Aug 25, 2020·American Journal of Obstetrics & Gynecology MFM·Margaux LouchetLaurent Mandelbrot
Apr 3, 2021·Therapeutic Advances in Neurological Disorders·Barbara Willekens, Ilka Kleffner
Apr 30, 2021·Frontline Gastroenterology·Christian P SelingerTracey Glanville
Jul 28, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Carla CarnovaleIrene Cetin
Jul 27, 2021·Birth Defects Research·Mireya Fernández-SánchezJose Luis Poveda-Andrés

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.